RESOURCES
Browse our content
Posters
Navigating Pitfalls in the Adenovirus Development: From Drug discovery to Clinics and beyond
June 6, 2024
![](https://exothera.world/wp-content/uploads/2024/05/ASGCT-NA.jpg)
Posters
Revolutionizing mRNA Production: the paradigm-breaking Ntensify™ continuous-batch RNA system
May 23, 2024
![](https://exothera.world/wp-content/uploads/2024/05/ASGCT-AAV.jpg)
Posters
Tackling AAV Manufacturing Process Industrialization Challenges Using A Standard Platform Approach
May 13, 2024
![](https://exothera.world/wp-content/uploads/2024/04/Slide-16_9-4-300x169.png)
Webinars
Increasing efficiency in AAV-based gene therapy production: platform optimization with multiserotype AAV affinity capture
April 16, 2024
![](https://exothera.world/wp-content/uploads/2024/04/cdmo-exothera-grows-north-american-tech-and-footprint-300x157.png)
Articles
CDMO Exothera grows North American tech and footprint
April 8, 2024
![](https://exothera.world/wp-content/uploads/2024/04/driving-innovation-in-nucleic-acid-therapeutics-300x157.png)
Articles
Driving Innovation in Nucleic Acid Therapeutics
April 8, 2024
![](https://exothera.world/wp-content/uploads/2024/02/REPLAY-300x169.png)
Webinars
How to achieve high titer cost-effective AAV production
February 6, 2024
![Biotech success in 2024](https://exothera.world/wp-content/uploads/2023/11/Webinar-300x157.png)
Webinars
Proactive Strategies for Biotech Success in the 2024 Landscape
November 9, 2023
![](https://exothera.world/wp-content/uploads/2023/07/Poster_Ovizio_Exothera-300x195.jpg)
Posters
Online monitoring of cell growth and shape in transient transfection process for AAV production in stirred tank bioreactor
July 4, 2023
![](https://exothera.world/wp-content/uploads/2023/06/Poster_LogicBio_Exothera-300x195.jpg)
Posters
Seamless scale-up of transient transfection process for rAAV production from shake flask to manufacturing-scale bioreactor
June 9, 2023
![](https://exothera.world/wp-content/uploads/2023/06/Polyplus_Webinarjju-300x195.jpg)
Webinars
Joint webinar with Bio-Rad Laboratories – Droplet Digital PCR (ddPCR): A Versatile Tool for Absolute Quantification and Quality Analysis of Viral Vector
June 7, 2023
![](https://exothera.world/wp-content/uploads/2023/06/daza-300x195.jpg)
Webinars
Joint webinar with Univercells Technologies – From tech transfer to commercial scale viral manufacturing in 8 months – a CDMO case study
June 1, 2023
![](https://exothera.world/wp-content/uploads/2023/03/Poster_ReiThera_Exothera_2-300x195.jpg)
Posters
Suspension based adenovirus production in scale-X™️ fixed-bed bioreactor
March 23, 2023
![](https://exothera.world/wp-content/uploads/2023/06/Polyplus_Webinar-300x195.jpg)
Webinars
Joint webinar with Univercells Technologies – Simplifying Seed Train: A Benchtop System for Intensified Inoculation of Large-Scale Bioreactors
January 24, 2023
![](https://exothera.world/wp-content/uploads/2022/11/Poster_exoREADY_DoE-300x195.jpg)
Posters
Design of Experiment, a powerful tool to simplify viral production process development
November 28, 2022
![](https://exothera.world/wp-content/uploads/2022/09/Critical_decisions_to_address_during_the_viral_vector_manuacturing_1080p-300x169.jpg)
Videos
Critical decision to address during the viral vector manufacturing
September 21, 2022
![](https://exothera.world/wp-content/uploads/2022/07/How-standardized-viral-vector-platforms-can-drive-better-service-from-CDMOs-1-300x193.png)
Articles
How standardized viral vector platforms can drive better service from CDMOs
July 12, 2022
![](https://exothera.world/wp-content/uploads/2022/07/PALL_Webinar-300x195.jpg)
Webinars
Joint webinar with Pall Corporations – Pall’s Accelerator℠ Integrated Solutions: Supporting Exothera to meet the high demand for viral vector GMP manufacturing.
June 21, 2022
![](https://exothera.world/wp-content/uploads/2022/07/Podcast_Hanna-300x195.jpg)
Podcasts
Using End-to-End Integrated Solutions to meet the High Demand for Viral Vector GMP Manufacturing
June 14, 2022
![](https://exothera.world/wp-content/uploads/2022/06/Polyplus_Webinar-300x195.jpg)
Webinars
Joint webinar with POLYPLUS – Taking a right first-time approach to optimize end-to-end viral vector manufacturing
June 9, 2022
![](https://exothera.world/wp-content/uploads/2022/07/CDMO-Benchmark-Report-300x195.jpg)
Reports
Biopharma CDMO Benchmark Report – What customers want from their CDMO
April 15, 2022
![](https://exothera.world/wp-content/uploads/2022/03/Serum-based-media-concerns-in-viral-vector-manufacturing-2-300x193.png)
Articles
Serum-based media concerns in viral vector manufacturing
March 15, 2022
![](https://exothera.world/wp-content/uploads/2022/01/Are-modern-scalable-bioreactors-the-right-cell-culture-strategy-for-gene-and-cell-therapy-success_-1-300x193.png)
Articles
Are modern scalable bioreactors the right cell culture strategy for gene and cell therapy success?
January 31, 2022
![](https://exothera.world/wp-content/uploads/2022/01/Gene-and-cell-therapy-manufacturing_-how-to-design-your-stable-cell-line-strategy_-1-300x193.png)
Articles
Gene and cell therapy manufacturing: how to design your stable cell line strategy?
January 5, 2022
![](https://exothera.world/wp-content/uploads/2021/12/Poster_Reithera-1-300x195.jpg)
Posters
Adaptation of suspension-based Adenovirus production process to scale-X™ technology
December 21, 2021
![](https://exothera.world/wp-content/uploads/2021/12/WP_Cell_Lines-300x195.jpg)
White Papers
The landscape for viral vector upstream processes – PROS and CONS
December 11, 2021
![](https://exothera.world/wp-content/uploads/2021/10/Timeline-300x195.jpg)
Infographics
Timeline of viral vector-based Cell & Gene therapy approvals
May 6, 2021
![](https://exothera.world/wp-content/uploads/2021/10/Product_approved-300x195.jpg)
Infographics
Worldwide approved gene therapies based on viral vectors
February 21, 2021
![](https://exothera.world/wp-content/uploads/2020/11/PLasmid-1-300x195.jpg)
Infographics
Plasmid manufacturing capacity around the world
November 30, 2020